Board Meeting9 Nov 2026, 04:11 pm
Vanta Bioscience Ltd Board Meeting on Nov 13, 2026 for Financial Results
AI Summary
Vanta Bioscience Ltd has announced that its Board of Directors will convene on November 13, 2026, to approve the standalone and consolidated unaudited financial results for the half-year ended September 30, 2026. The meeting will also include a review of the Limited Review Report from the statutory auditors. In line with the Insider Trading Policy, the trading window for designated persons remains closed from October 1, 2026, to November 15, 2026.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- To approve unaudited financial results for H1 FY27.
- Limited Review Report by auditors to be noted.
- Trading window closed for designated persons until November 15, 2026.
Price Impact
More from VANTABIO